Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CAPECITABINE\OXALIPLATIN Cause Malignant neoplasm progression? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Malignant neoplasm progression have been filed in association with CAPECITABINE\OXALIPLATIN. This represents 8.9% of all adverse event reports for CAPECITABINE\OXALIPLATIN.

8
Reports of Malignant neoplasm progression with CAPECITABINE\OXALIPLATIN
8.9%
of all CAPECITABINE\OXALIPLATIN reports
2
Deaths
3
Hospitalizations

How Dangerous Is Malignant neoplasm progression From CAPECITABINE\OXALIPLATIN?

Of the 8 reports, 2 (25.0%) resulted in death, 3 (37.5%) required hospitalization.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CAPECITABINE\OXALIPLATIN. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does CAPECITABINE\OXALIPLATIN Cause?

Diarrhoea (11) Death (8) Neuropathy peripheral (6) Therapy partial responder (6) Colorectal cancer metastatic (5) Enterocolitis (5) Nausea (5) Osteonecrosis of jaw (5) Product use in unapproved indication (5) Vomiting (5)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Related Pages

CAPECITABINE\OXALIPLATIN Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression CAPECITABINE\OXALIPLATIN Demographics